BMC Medical Research Methodology

Papers
(The H4-Index of BMC Medical Research Methodology is 39. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Estimation of marginal structural models under irregular visits and unmeasured confounder: calibrated inverse probability weights421
A Bayesian network perspective on neonatal pneumonia in pregnant women with diabetes mellitus337
Statistical methods in the analysis of multicentre HIV randomized controlled trials in the African region: a scoping review187
CalScope: methodology and lessons learned for conducting a remote statewide SARS-CoV-2 seroprevalence study in California using an at-home dried blood spot collection kit and online survey161
Technologies for frailty, comorbidity, and multimorbidity in older adults: a systematic review of research designs143
Clinical systematic reviews – a brief overview120
The role and challenges of clinical research coordinators: insights from a national survey107
A randomized Bayesian phase I-II dose optimization design for combination cancer therapies with progression-free survival end point106
Towards robust electronic health record systems: integrating formal verification and process modeling techniques102
Comparing statistical methods in assessing the prognostic effect of biomarker variability on time-to-event clinical outcomes96
How likely is unmeasured confounding to explain meta-analysis-derived associations between alcohol, other substances, and mood-related conditions with HIV risk behaviors?95
regCOVID: Tracking publications of registered COVID-19 studies93
Causal effect of chemotherapy received dose intensity on survival outcome: a retrospective study in osteosarcoma90
Could master protocols be adapted for effectiveness-implementation hybrid studies?83
Choices of measures of association affect the visualisation and composition of the multimorbidity networks82
Correction: In health research publications, the number of authors is strongly associated with collective self-citations but less so with citations by others79
Understanding facilitators of research participation among adults with self-reported chronic pain – a survey examining hypothetical research participation77
Recruitment of a probability-based general population health panel for public health research in Germany: the panel ‘Health in Germany’73
Should RECOVERY have used response adaptive randomisation? Evidence from a simulation study72
More than one third of clinical practice guidelines on low back pain overlap in AGREE II appraisals. Research wasted?72
The impact of iterative removal of low-information cluster-period cells from a stepped wedge design72
Modelling of intensive care unit (ICU) length of stay as a quality measure: a problematic exercise61
MetaAnalyst: a user-friendly tool for metagenomic biomarker detection and phenotype classification56
A framework to model global, regional, and national estimates of intimate partner violence53
A gated group sequential design for seamless Phase II/III trial with subpopulation selection52
Developing survey weights to ensure representativeness in a national, matched cohort study: results from the children and young people with Long Covid (CLoCk) study50
Design and analysis of outcomes following SARS-CoV-2 infection in veterans49
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group48
External validation of existing dementia prediction models on observational health data48
Improving the efficiency of drug resistant tuberculosis treatment trials: a time-to-event alternative marker for bacteriological response and adaptive minimization for randomization45
Handling of missing component information for common composite score outcomes used in axial spondyloarthritis research when complete-case analysis is unbiased45
Comparing methods for handling missing data in electronic health records for dynamic risk prediction of central-line associated bloodstream infection45
Contextual effects: how to, and how not to, quantify them44
Estimating comparative effectiveness using Single-Arm trials: A challenge in the field of agnosticism44
A data-driven pipeline to extract potential adverse drug reactions through prescription, procedures and medical diagnoses analysis: application to a cohort study of 2,010 patients taking hydroxychloro41
Using group testing in a two-phase epidemiologic design to identify the effects of a large number of antibody reactions on disease risk40
Fidelity, pragmatism and the “grey line” in between—exploring the delivery of a pragmatic physical activity randomised controlled trial—a secondary analysis40
Development and validation of paired MEDLINE and Embase search filters for cost-utility studies39
Optimising research investment by simulating and evaluating monitoring strategies to inform a trial: a simulation of liver fibrosis monitoring39
Discretizing multiple continuous predictors with U-shaped relationships with lnOR: introducing the recursive gradient scanning method in clinical and epidemiological research39
0.17493391036987